跳至主要内容
临床试验/CTRI/2025/04/085507
CTRI/2025/04/085507招募中不适用

The platelet to albumin ratio a predictive marker in assessment of diabetic nephropathy among type 2 diabetes mellitus

Komal Dhamanekar1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2025年6月5日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
120
试验地点
1
主要终点
Role of Platelet to Albumin ratio in Diabetic Nephropathy among T2DM

研究概览

简要总结

Diabeticnephropathy is a leading cause of chronic kidney diseases and Endstagerenal failure, affecting approximately 40% of patients with T2DM.Earlydetection of diabetic nephropathy plays crucial role in mitigating diseaseprogression ,This study aims to contribute to development of more effectivediagnostic and predictive marker for diabetic nephropathy in T2DM patients

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Case: Patients with T2DM Control: Non diabetic patients.

排除标准

  • Acute or chronic infections Auto immune diseases Tumors Heamatological Diseases Liver insufficiency.

结局指标

主要结局

Role of Platelet to Albumin ratio in Diabetic Nephropathy among T2DM

时间窗: 24 Weeks

次要结局

未报告次要终点

研究者

发起方
Komal Dhamanekar
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验